Skip to main content
NanoVibronix, Inc. logo

NanoVibronix, Inc. — Investor Relations & Filings

Ticker · NAOV ISIN · US63008J7028 LEI · 5493008114LTFZQ2I595 US Manufacturing
Open in API
Filings indexed 512 across all filing types
Latest filing 2020-01-30 Regulatory Filings
Country US United States of America
Listing US NAOV

About NanoVibronix, Inc.

https://nanovibronix.com/

NanoVibronix, Inc. is a medical technology company that develops non-invasive and minimally invasive biological response-activating devices. The company's core technology is based on a proprietary, patented low-intensity surface acoustic wave (SAW) ultrasound. Its main products include PainShield®, a portable device for pain therapy and the treatment of nerve and soft tissue damage, and UroShield®, an ultrasound device designed to prevent bacterial biofilm on urinary catheters. These prescription-based products offer therapeutic alternatives to medication for pain management, wound healing, and biofilm prevention, targeting both clinical and home care settings.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2020
Regulatory Filings
2020-01-30 English
Regulatory Filings 2020
Regulatory Filings Classification · 90% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, or references to specific report types, fiscal periods, or regulatory bodies. Without any discernible information or context, it is impossible to classify this document as any specific financial filing type. Given the lack of meaningful content, the appropriate classification is the fallback category, Regulatory Filings (RNS), which covers miscellaneous filings that do not fit into other categories.
2020-01-28 English
Capital/Financing Update 2020
Capital/Financing Update Classification · 95% confidence The document is a letter from NanoVibronix, Inc. to the SEC requesting acceleration of the effective date of a Registration Statement under the Securities Act of 1933. It references Rule 461 and a File Number 333-236000, which indicates it is related to a registration or capital raising process. The document is short (1141 characters) and is a formal correspondence rather than a financial report or detailed filing. It does not contain financial statements or detailed disclosures but is a procedural request related to a registration statement effectiveness. Therefore, it fits best under Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2020-01-27 English
REGISTRATION STATEMENT
Capital/Financing Update Classification · 100% confidence The document is a Form S-3 Registration Statement filed with the SEC, which is used for registering securities for sale to the public. It includes details about the securities being registered, the selling stockholders, and the terms of the offering. This type of filing is related to capital raising and financing activities. It is not an annual report, earnings release, or any other type of financial or governance report. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is the actual registration statement, not just an announcement or notice.
2020-01-21 English
OWNERSHIP DOCUMENT
Director's Dealing
2019-12-06 English
OWNERSHIP DOCUMENT
Director's Dealing
2019-12-06 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.